Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TXA Nebulization for Hemoptysis
NCT05648656Phase 3Unknown
- Sponsor
- Post Graduate Institute of Medical Education and Research
- Start
- Feb 2022
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tranexamic acid in hemoptysis, sponsored by Post Graduate Institute of Medical Education and Research. Primary endpoints: Frequency of hemoptysis at 48 hours, Quantity of hemoptysis at 48 hours and 1 more. Status: unknown.
02
Drugs
tranexamic acid
03
Conditions
hemoptysis
Beyond the preview
Go deeper on NCT05648656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05648656.